XML 94 R81.htm IDEA: XBRL DOCUMENT v3.19.2
Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Segment Reporting Information [Line Items]        
Dialysis and related lab patient service revenues $ 2,734,065 $ 2,718,403 $ 5,369,217 $ 5,309,477
Provision for uncollectible accounts (10,249) (49,406) (15,712) (23,861)
Net U.S. dialysis and related lab services patient service revenues 2,723,816 2,668,997 5,353,505 5,285,616
Other revenues 118,889 217,956 232,312 450,781
Total revenues 2,842,705 2,886,953 5,585,817 5,736,397
Operating income (loss) 461,886 438,192 802,393 848,878
Corporate administrative support (22,021) (14,066) (40,866) (29,769)
Debt expense (131,666) (119,692) (263,185) (233,208)
Debt prepayment charges (12,160) 0 (12,160) 0
Other income, net 5,643 1,994 12,583 6,576
Income from continuing operations before income taxes 323,703 320,494 539,631 622,246
U.S. dialysis and related lab services        
Segment Reporting Information [Line Items]        
Total revenues 2,607,160 2,568,247 5,123,670 5,087,724
Other—Ancillary services and strategic initiatives        
Segment Reporting Information [Line Items]        
Total revenues 235,545 318,706 462,147 648,673
Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 2,876,442 2,916,238 5,653,531 5,794,303
Operating income (loss) 483,907 452,258 843,259 878,647
Operating Segments | U.S. dialysis and related lab services        
Segment Reporting Information [Line Items]        
Dialysis and related lab patient service revenues 2,642,242 2,632,830 5,189,951 5,140,418
Provision for uncollectible accounts (10,249) (49,406) (15,712) (24,208)
Net U.S. dialysis and related lab services patient service revenues 2,631,993 2,583,424 5,174,239 5,116,210
Total revenues 2,637,494 2,588,343 5,184,645 5,126,243
Operating income (loss) 498,957 449,443 915,939 882,822
Operating Segments | U.S. dialysis and related lab services | External Sources        
Segment Reporting Information [Line Items]        
Dialysis and related lab patient service revenues 2,612,200 2,612,734 5,129,489 5,101,899
Other revenues 5,209 4,919 9,893 10,033
Operating Segments | U.S. dialysis and related lab services | Intersubsegment Eliminations        
Segment Reporting Information [Line Items]        
Dialysis and related lab patient service revenues 30,042 20,096 60,462 38,519
Other revenues 292 0 513 0
Operating Segments | Other—Ancillary services and strategic initiatives        
Segment Reporting Information [Line Items]        
Dialysis and related lab patient service revenues 121,865 105,669 239,728 207,925
Other revenues 113,680 213,037 222,419 440,748
Total revenues 238,948 327,895 468,886 668,060
Operating income (loss) (15,050) 2,815 (72,680) (4,175)
Operating Segments | Other—Ancillary services and strategic initiatives | Intersubsegment Eliminations        
Segment Reporting Information [Line Items]        
Dialysis and related lab patient service revenues 3,403 9,189 6,739 19,387
Intersegment Elimination        
Segment Reporting Information [Line Items]        
Total revenues (33,737) (29,285) (67,714) (57,906)
Intersegment Elimination | U.S. dialysis and related lab services        
Segment Reporting Information [Line Items]        
Total revenues (30,334) (20,096) (60,975) (38,519)
Intersegment Elimination | Other—Ancillary services and strategic initiatives        
Segment Reporting Information [Line Items]        
Total revenues $ (3,403) $ (9,189) $ (6,739) $ (19,387)